DEC 17, 2018 11:06 PM PST

A Migraine Associated Specific Mutation Increases Neuronal Excitability

Migraine, the third most common disease globally is a severe disabling pain that is often accompanied by nausea, vomiting and extreme light and sound sensitivity. Around one in seven people suffer from this debilitating pain, which can last anywhere between hours to days.  This painful headache sure seems to be a headache that needs to be resolved.

Genetic mutations and environmental factors play a critical role in migraine onset. A study published earlier in 2018 on May 3 in the journal Neuron shows why some families are susceptible to migraines and how genetics may influence the type of a migraine they get. Approximately 44 genetic variants have been identified, that possibly relate to migraine. Researchers have carried out the most extensive genetic family study on migraines based on medical history and genetic data of 1,589 Finnish migraine families with more than 8,300 individuals. However, none of these variants are specifically related to the different migraine types.

Clinically, there are two types of migraine, 1. Migraine with aura(MA), where transient neurological disturbances precede migraine and 2) Migraine without aura (MO). The aura is hypothesized to be due to the activation and sensitization of trigeminal neurons (TG), which in turn release pro-inflammatory peptides that possibly initiate and transmit the pain.

Recent findings have identified a potential role of two-pore-domain potassium (K2P) channels in pain processing. One subtype of K2P channel expressed in sensory neurons, TRESK has been reported to play a role in MA in its truncated from TRESK-MT. TRESK-MT induces hyperexcitability in TG neurons. Another mutation of TRESK, TRSEK-C110R negatively effects migraine and is present in the control cohort as well.

The opposite effects on migraine by the TRESK mutations prompted the researchers at University Cote d’Azur, CNRS, Inserm, Institut de Biologie Valrose, Nice, France to investigate the exact role of TRESK in migraine. The study done in mice identified that TSERK-MT inhibits TREK1 and TREK2 channels, also related to K2P family, which in turn increase TG neuronal excitability and thus potentially cause migraines. Alternatively, TRESK-C110R does not regulate the TREK channels. These results, published in Neuron on December 17, 2018, open a new path for the development of anti-migraine medicines. A patent application has been filed*: the scope is targeting K2P2.1 channels to reduce the electrical activity of neurons and prevent migraines from being triggered.

Image Credit: Guillaume Sandoz, CNRS

The results also identified another secondary product MT2, by the alternative translation initiation in response to the TRESK mutation, which mediates the inhibition of TREK channels. Both TRESK and TREK channels are co-expressed by the sensory neurons, and this was confirmed through immunohistochemistry, single-cell RT-PCR and pharmacology in mice. TRESK interacts with TREK1/2 but not with the other subfamilies of K2P with such affinity. The heteromerization of the TRESK and TREK’s needs further research to understand the exact mechanics.

TRESK-MT induced inhibition of TREK1/2 reduces the lamotrigine-sensitive potassium ion current, and this activates the TG neurons. Knock out mice for both TREK1/2 showed an increase sensory neuron excitability that possibly induces migraine.

What is more, the researchers propose that this new genetical mechanism, causing the formation of two proteins instead of just one, has now to be considered for the study of other genetic diseases and for diagnosing them.

Watch the animation to understand migraine and genetic mutations.

* Patent PCT/EP2018/067581 “Methods and compositions for treating migraine.”

Sources: Neuron

About the Author
  • Aswini Kanneganti is an experienced research scientist from Dallas, Texas. Her interests include neuroscience, medical devices, and neuromodulation.
You May Also Like
FEB 04, 2020
FEB 04, 2020
Revealing How a Common Virus Evades the Immune System
The human metapneumovirus (HMPV) might now be well-known, but it is the second biggest cause of respiratory infections....
FEB 18, 2020
Cell & Molecular Biology
FEB 18, 2020
How Too Much Fluoride Can Disrupt Tooth Enamel
You can have too much of a good thing....
FEB 24, 2020
Clinical & Molecular DX
FEB 24, 2020
Nanoparticles provide momentum for better diagnostic imaging
Photoacoustic imaging is an emerging tool with a vast array of biomedical applications ranging from the detection of brain lesions to imaging early signs o...
FEB 21, 2020
FEB 21, 2020
Poor Sleep Increases Heart Disease Risk in Women
Researchers from Columbia University Irving Medical Center have found that women who don’t sleep well leading tend to have a lower quality diet and t...
FEB 21, 2020
Clinical & Molecular DX
FEB 21, 2020
Diagnosing COVID-19
Diagnosing coronavirus is done through next-generation sequencing, real-time RT-PCR tests, cell culture, and electron miscopy. For patients, that translate...
FEB 27, 2020
Drug Discovery & Development
FEB 27, 2020
New Drug Shows Promise in Treating Chronic Cough
Between 4% and 10% of adults around the world have an unexplainable chronic cough that has lasted for over 8 weeks. Although no treatments are currently av...
Loading Comments...